Equities Analysts Offer Predictions for Bioceres Crop Solutions Corp.’s Q1 2025 Earnings (NASDAQ:BIOX)

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Investment analysts at Brookline Capital Management issued their Q1 2025 EPS estimates for shares of Bioceres Crop Solutions in a note issued to investors on Tuesday, September 10th. Brookline Capital Management analyst K. Dolliver anticipates that the company will earn $0.09 per share for the quarter. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.81 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q2 2025 earnings at $0.28 EPS, Q3 2025 earnings at $0.09 EPS, Q4 2025 earnings at $0.13 EPS, FY2025 earnings at $0.59 EPS, FY2026 earnings at $0.93 EPS, FY2027 earnings at $1.18 EPS and FY2028 earnings at $1.32 EPS.

Other equities research analysts have also recently issued research reports about the stock. Oppenheimer reduced their target price on shares of Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating for the company in a research report on Wednesday. Roth Capital raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Tuesday, July 2nd. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Canaccord Genuity Group cut their price target on Bioceres Crop Solutions from $17.00 to $12.50 and set a “buy” rating for the company in a research note on Wednesday. Finally, Lake Street Capital reduced their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday. Four investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $13.63.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ BIOX opened at $8.56 on Friday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.28 and a quick ratio of 0.83. The firm has a market cap of $537.57 million, a price-to-earnings ratio of 856.00 and a beta of 0.49. The stock’s fifty day moving average price is $10.43 and its two-hundred day moving average price is $11.42. Bioceres Crop Solutions has a one year low of $8.16 and a one year high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its earnings results on Monday, September 9th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.20 by ($0.23). The firm had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. Bioceres Crop Solutions had a net margin of 0.68% and a return on equity of 0.93%. During the same period in the previous year, the company posted ($0.06) EPS.

Institutional Trading of Bioceres Crop Solutions

Large investors have recently made changes to their positions in the company. Oak Family Advisors LLC raised its position in Bioceres Crop Solutions by 1.9% during the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after purchasing an additional 1,208 shares in the last quarter. Activest Wealth Management acquired a new position in shares of Bioceres Crop Solutions during the 1st quarter worth $30,000. Cape Investment Advisory Inc. bought a new stake in shares of Bioceres Crop Solutions during the 4th quarter worth $33,000. Dimensional Fund Advisors LP boosted its stake in Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares in the last quarter. Finally, Wellington Management Group LLP grew its position in Bioceres Crop Solutions by 3.1% in the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after acquiring an additional 7,096 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.